Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein phosphatase 1 regulatory subunit 26 (PPP1R26) is a regulatory protein that interacts with and inhibits the phosphatase activity of protein phosphatase 1 (PP1) complexes. By binding to PP1, PPP1R26 modulates the activity, localization, and substrate specificity of the PP1 holoenzyme. PP1 regulatory subunits, including PPP1R26, are key determinants of cellular signaling specificity, but there is no evidence indicating that PPP1R26 functions as a receptor, enzyme, transporter, or established therapeutic target. No known drugs or clinically relevant small molecules are reported to target PPP1R26 specifically[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein phosphatase 1 regulatory subunit 26 (PPP1R26).